ARCHIVES

FDA, NCI, CMS Announce Biomarker Initiative; First Project To Validate FDG-PET As Predictor Of Tumor Response In Non-Hodgkin’s Lymphoma.

This article is from The Cancer Letter archive.

Vol. 32 No. 06 | February 17, 2006

Download PDF Visit The Full Archive

Related Articles

Thomas Jordan To Help ASCO Enhance International Relations, Retires From BMS.

February 15, 2002

Clinical Trial Participants Sue Duke University, Potti, Nevins and Others for Causing Harm

September 9, 2011

French Cancer Group Vow to Spend More On Cancer Research

January 12, 1996

Bristol-Myers Adds UCLA, Fox Chase To Grants Program

April 12, 1985

In Brief: NCI Contract Plans Shaping Up As RFP “Season” Approaches; L-B Profit Told

September 13, 1974

Democrats Say Bush Budget Neglects NSF And NASA.

March 23, 2001